Literature DB >> 12942273

Fluorescence diagnosis: a novel method to guide radical inguinal lymph node dissection in penile cancer.

D Frimberger1, R Linke, H Meissner, H Stepp, D Zaak, E Hungerhuber, R Waidelich, N Schmeller, A Hofstetter, P Schneede.   

Abstract

In penile cancer there is still a diagnostic dilemma between over treatment of lymph node-negative patients and the missing of occult metastases by watchful waiting. In the current study the value of fluorescence diagnosis during radical inguinal lymph node dissection was evaluated. Five patients with penile cancer were elected to undergo groin dissection. All patients received 5-aminolevulinic acid (5-ALA) orally before the operation for fluorescence diagnosis. Intraoperatively, fluorescence detection of the lymph nodes was performed by visual detection and spectroscopy. Two of the five patients had positive inguinal lymph nodes. Fluorescence in tumor-bearing tissue was detectable in the exposed lymph nodes. Protoporphyrin IX (PPIX) is accumulated in tumor-positive lymph nodes, making fluorescence diagnosis in penile cancer possible. More studies with higher patient numbers are necessary to evaluate optimal dosage and excitation conditions to detect tumor-bearing nodes in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12942273     DOI: 10.1007/s00345-003-0352-1

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  19 in total

Review 1.  Endoscopic fluorescence diagnosis and laser treatment of transitional cell carcinoma of the bladder.

Authors:  D Frimberger; D Zaak; A Hofstetter
Journal:  Semin Urol Oncol       Date:  2000-11

2.  Cabanas approach: is sentinel node biopsy reliable for staging penile carcinoma?

Authors:  E Wespes; J Simon; C C Schulman
Journal:  Urology       Date:  1986-10       Impact factor: 2.649

3.  First experience with gamma probe guided sentinel lymph node surgery in penile cancer.

Authors:  F Wawroschek; H Vogt; D Bachter; D Weckermann; M Hamm; R Harzmann
Journal:  Urol Res       Date:  2000-08

4.  Surgical treatment of invasive penile cancer--the Heidelberg experience from 1968 to 1994.

Authors:  D Brkovic; T Kälble; J Dörsam; S Pomer; C Lötzerich; R Banafsche; G Riedasch; G Staehler
Journal:  Eur Urol       Date:  1997       Impact factor: 20.096

5.  Unreliability of sentinel lymph node biopsy for staging penile carcinoma.

Authors:  E Perinetti; D B Crane; W J Catalona
Journal:  J Urol       Date:  1980-11       Impact factor: 7.450

6.  Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells.

Authors:  P Steinbach; M Kriegmair; R Baumgartner; F Hofstädter; R Knüchel
Journal:  Urology       Date:  1994-11       Impact factor: 2.649

7.  Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas.

Authors:  A M Hussein; P Benedetto; K S Sridhar
Journal:  Cancer       Date:  1990-02-01       Impact factor: 6.860

8.  Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes.

Authors:  S Horenblas; H van Tinteren; J F Delemarre; L M Moonen; V Lustig; E W van Waardenburg
Journal:  J Urol       Date:  1993-03       Impact factor: 7.450

9.  Carcinoma of the penis: improved survival by early regional lymphadenectomy based on the histological grade and depth of invasion of the primary lesion.

Authors:  W S McDougal
Journal:  J Urol       Date:  1995-10       Impact factor: 7.450

10.  Modified inguinal lymphadenectomy for carcinoma of the penis with preservation of saphenous veins: technique and preliminary results.

Authors:  W J Catalona
Journal:  J Urol       Date:  1988-08       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.